Publication | Closed Access

Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses

Nanovaccine AugmentsNanomedicineCell-based Drug DeliveryT-cell ResponsesImmunologyTherapeutic VaccineCo-localized DeliveryNano-drug DeliveryTumor TargetingImmune Cell TherapyImmunotherapyMedicineRadiation OncologyTumor Microenvironment